Table III.
Baseline vitals, laboratory parameters, hospital course, treatment details and outcomes of the admitted COVID-19 patients (n=144)
| Parameter at admission | n (%) |
|---|---|
| Fever (≥37.3°C) | 16 (11.1) |
| RR (breaths/min)# | 18 (16-18) |
| SpO2(%)* | 95.6±13.8 |
| Heart rate (beats/min)* | 85.0±14.0 |
| Systolic blood pressure (mmHg)* | 111.6±15.6 |
| Diastolic blood pressure (mmHg)* | 78.1±11.7 |
| Heart rate >110/min | 4 (2.8) |
| RR >24 breaths per minute | 4 (2.8) |
| SpO2<94% | 3 (2.1) |
| Systolic blood pressure <90 mmHg | 1 (0.7) |
| Disease severity status at baseline | |
| Mild to moderate | 140 (97.2) |
| Severe | 4 (2.8) |
| Laboratory findings | |
| Hb (g %)* | 14.1±1.4 |
| Platelet count (105/μl)# | 3.3 (2.9-4.0) |
| Anaemia | 5 (3.5) |
| TLC (per μl)# | 8460 (6900-9790) |
| TLC grading (per µl) | |
| 4,000-11,000 | 121 (84) |
| >11,000 | 15 (10.4) |
| Neutrophil: lymphocyte ratio# | 1.9 (1.5-2.6) |
| Lymphopenia | 9 (6.3) |
| Serum proteins (g/dl)* | 6.9±0.7 |
| Serum albumin (g/dl)* | 4.3±0.5 |
| Bilirubin (mg/dl)# | 0.5 (0.4-0.7) |
| ALT (units/l)# | 28.3 (24.8-38.8) |
| AST (units/l)# | 30.5 (21.0-46.7) |
| Alkaline phosphatase (units/l)# | 79 (67.7-97.5) |
| Radiologic findings (n=18) | |
| Normal | 9 (50) |
| Lobar consolidation with bilateral interstitial infiltrates | 4 (22.2) |
| Patchy bilateral infiltrates | 3 (16.6) |
| Cavitation along with bilateral interstitial infiltrates | 2 (11.1) |
| Drugs received | |
| Paracetamol | 30 (20.8) |
| Antihistamines | 70 (48.6) |
| Oral vitamin C | 68 (47.2) |
| Azithromycin | 29 (20.1) |
| HCQ | 27 (18.7) |
| Both azithromycin and HCQ | 11 (7.6) |
| Beta-lactam/beta-lactamase inhibitor | 7 (4.9) |
| Teicoplanin | 1 (0.7) |
| Antitubercular treatment | 1 (0.7) |
| Hospital course and outcome | |
| Time to RT-PCR negativity (days)* | 16.9±2.9 |
| Improved | 139 (96.5) |
| Worsening requiring shifting to ICU/high-dependency unit | 5 (3.5) |
| MV | 1 (0.7) |
| Outcome | |
| Transferred out | 1 (0.7) |
| Death | 2 (1.4) |
| Cured | 125 (86.8) |
| Still admitted | 16 (11.1) |
*Values in mean±SD; #Values in median (IQR). SpO2, oxygen saturation; RR, respiratory rate; TLC, total leucocyte count; ALT, alanine aminotransferase; AST, aspartate aminotransferase; MV, mechanical ventilation; RT-PCR, reverse transcription-polymerase chain reaction; Hb, haemoglobin; HCQ, hydroxychloroquine; ICU, intensive care unit